Clinicopathological association analysis revealed that Wnt10a was significantly associated with high-grade and late-stage ovarian cancer, which suggested that Wnt10a serves an oncogenic role during the carcinogenesis and progression of ovarian cancer (13). Here, WNT10A is linked to ovarian carcinoma.